Hannu T. Aro

Corporate Officer/Principal en University of Turku .

Consumer Services

Health Technology

Perfil

Hannu T.
Aro is currently a Professor at the University of Turku.
Previously, he worked as a Director at BonAlive Biomaterials Oy and as a Principal at The Johns Hopkins University.

Cargos activos de Hannu T. Aro

Empresas	Cargo	Inicio
University of Turku	Corporate Officer/Principal	13/09/2010

Todos los cargos activos de Hannu T. Aro

Antiguos cargos conocidos de Hannu T. Aro.

Empresas	Cargo	Fin
The Johns Hopkins University	Corporate Officer/Principal	-
BonAlive Biomaterials Oy BonAlive Biomaterials Oy Medical SpecialtiesHealth Technology BonAlive Biomaterials Oy is a holding company that provides solutions to heal patients with bone defects. It develops synthetic biomaterial solutions for the treatment of chronically infected bone. Their products include BonAlive granules and BonAlive putty, which are osteostimulative; BonAlive granules, which inhibits bacterial growth and act as tool for bone cavity filling in the treatment of chronic osteomyelitis; and BonAlive plates, which have been designed for repair of orbital floor trauma. The company was founded by Fredrik Viktor Ollila on November 13, 2009 and is headquartered in Turku, Finland.	Director/Miembro de la Junta	-

Ver el detalle de la experiencia de Hannu T. Aro.

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Ver el detalle de la experiencia de Hannu T. Aro.

Relaciones

Relaciones de 1er grado

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Consultar la red personal

Empresas relacionadas

Empresas privadas	1
BonAlive Biomaterials Oy BonAlive Biomaterials Oy Medical SpecialtiesHealth Technology BonAlive Biomaterials Oy is a holding company that provides solutions to heal patients with bone defects. It develops synthetic biomaterial solutions for the treatment of chronically infected bone. Their products include BonAlive granules and BonAlive putty, which are osteostimulative; BonAlive granules, which inhibits bacterial growth and act as tool for bone cavity filling in the treatment of chronic osteomyelitis; and BonAlive plates, which have been designed for repair of orbital floor trauma. The company was founded by Fredrik Viktor Ollila on November 13, 2009 and is headquartered in Turku, Finland.	Health Technology